BioCentury
ARTICLE | Clinical News

VivaGel: Feasibility study data

August 10, 2009 7:00 AM UTC

In an open-label, crossover, Australian feasibility study in 11 healthy women, CV fluid samples taken immediately after vaginal administration of VivaGel completely inhibited HIV and HSV-2 infection e...